MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALMON, R. R.
Right arrow Articles by MARTNER, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ALMON, R. R.
Right arrow Articles by MARTNER, J. E.

Molecular Pharmacology, Vol 17, 141-148, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Muscarinic Sites in the Amphibian Central Nervous System: Characterization and Temperature Studies

RICHARD R. ALMON 1 and JOHN E. MARTNER 1

1 Division of Cell and Molecular Biology, Department of Biological Sciences, State University of New York at Buffalo, Buffalo, New York 14260

Associations of the muscarinic cholinergic antagonist [3H]quinuclidinyl benzilate (3H-QNB) with neural membranes from the frog (Rana pipiens pipiens) are described. This ligand interacts with a single set of identical independent sites on these membranes. The set of sites has characteristics suggesting that it represents a population of muscarinic receptor structures. The first thermodynamic association constant of 3H-QNB with the set of sites is 1.7 ± 0.53 x 109 M-1. The pseudo-first-order rate constant of association is 2.74 ± 0.42 x 106 M-1 sec-1. Temperature studies demonstrate several transitions in both the kinetic and thermodynamic properties of association. Finally, when membrane composition is modified by temperature acclimation of the animals, significant changes are observed in both antagonist and agonist interactions with the receptor structure.

Submitted on May 14, 1979
Accepted on September 27, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics